Cargando…
Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza
Delivering rapid protection against infectious agents to non-immune populations is a formidable public health challenge. Although passive immunotherapy is a fast and effective method of protection, large-scale production and administration of monoclonal antibodies (mAbs) is expensive and unpractical...
Autores principales: | Michelini, Zuleika, Minkoff, Judith M., Yang, Jianjun, Negri, Donatella, Cara, Andrea, Hanson, Brendon J., Salvatore, Mirella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767071/ https://www.ncbi.nlm.nih.gov/pubmed/33348840 http://dx.doi.org/10.3390/v12121460 |
Ejemplares similares
-
Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice
por: Fontana, Judith M., et al.
Publicado: (2014) -
Intranasal Administration of Integrase Defective Lentiviral Vectors Expressing mAbs Protects from H5 Influenza Virus Challenge In Vivo
por: Michelini, Zuleika, et al.
Publicado: (2017) -
Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
por: Gallinaro, Alessandra, et al.
Publicado: (2018) -
Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
por: Morante, Valeria, et al.
Publicado: (2021) -
Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector
por: Rossi, Alessandra, et al.
Publicado: (2014)